Pulsenmore Ltd. (PLSM)
NASDAQ: PLSM · Real-Time Price · USD
4.030
-0.170 (-4.05%)
Mar 23, 2026, 4:00 PM EDT - Market closed
Pulsenmore Revenue
Pulsenmore had revenue of 4.00M ILS in the half year ending June 30, 2025, with 64.57% growth. This brings the company's revenue in the last twelve months to 9.31M, up 14.82% year-over-year. In the year 2024, Pulsenmore had annual revenue of 9.66M with 56.12% growth.
Revenue (ttm)
9.31M ILS
Revenue Growth
+14.82%
P/S Ratio
9.53
Revenue / Employee
160,517 ILS
Employees
58
Market Cap
26.33M USD
Revenue Chart
* This company reports financials in ILS.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.66M | 3.47M | 56.12% |
| Dec 31, 2023 | 6.19M | -4.63M | -42.78% |
| Dec 31, 2022 | 10.81M | 9.24M | 585.30% |
| Dec 31, 2021 | 1.58M | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Nortech Systems | 116.67M |
| TELA Bio | 77.06M |
| IRIDEX | 50.65M |
| Myomo | 40.93M |
| Cytosorbents | 36.98M |
| NeuroOne Medical Technologies | 11.72M |
| VolitionRx | 1.47M |
PLSM News
- 6 weeks ago - Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance - PRNewsWire
- 7 weeks ago - Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center - PRNewsWire
- 2 months ago - Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation - PRNewsWire
- 2 months ago - Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S. - PRNewsWire